On Tuesday 12 november 2024, S. Franssen will defend the doctoral thesis titled: Locoregional Treatments for Biliary Cancer: Intra-arterial chemotherapy and primary percutaneous stenting
- Promotor
- Co-promotor
- Co-promotor
- Co-promotor
- Date
- Tuesday 12 Nov 2024, 15:30 - 17:00
- Type
- PhD defence
- Space
- Professor Andries Querido room
- Building
- Education Center
- Location
- Erasmus MC
Below is a brief summary of the dissertation:
Biliary cancer is associated with a poor prognosis. Most patients are only eligible for palliative systemic treatment with a median overall survival of 12 months. In patients with jaundice the prognosis is even worse with a median overall survival of 6 months, due to complications of endoscopic biliary drainage. During my PhD research period, we started new locoregional treatments for patients with inoperable biliary cancer to improve survival and quality of life.
In the PUMP II trial patients with unresectable intrahepatic cholangiocarcinoma received hepatic arterial infusion pump chemotherapy combined with standard systemic chemotherapy. In the TESLA trial, patients with jaundice due to a malignant hilar biliary obstruction underwent primary percutaneous stenting without passing the ampulla and without leaving an external biliary drain.
- More information
The public defence will start exactly at 15.30pm. The doors will be closed once the public defence starts, latecomers can access the hall via the fourth floor. Given the solemn nature of the meeting, we advise not to bring children under the age of 6 to the first part of the ceremony.
A livestream link has been provided to candidate.
